Imipenem Export Market Intelligence: India's 140 Suppliers Shipping to 94 Countries — TransData Nexus 2026

Q: Who are the top imipenem exporters from India?

The top imipenem exporters from India are: 1. VENUS REMEDIES LIMITED — $13.5M (40.6% market share); 2. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $8.3M (24.9% market share); 3. SWISS PARENTERALS LIMITED — $2.1M (6.3% market share); 4. SUN PHARMACEUTICAL INDUSTRIES LTD — $1.3M (4.0% market share); 5. PROTECH BIO SYSTEMS PRIVATE LIMITED — $1.3M (4.0% market share). Together they account for 79.7% of India's total imipenem export value.

Q: What is the total export value of imipenem from India?

The total export value of imipenem from India is $33.3M USD, recorded across 803 shipment transactions from 140 active exporters to 94 destination countries. The average shipment value is $41.5K.

Q: Which countries import imipenem from India?

India exports imipenem to 94 countries worldwide. The top importing countries are: MEXICO (27.2% share, $9.1M), BELGIUM (10.0% share, $3.3M), SRI LANKA (7.4% share, $2.5M), MOROCCO (7.4% share, $2.5M), MYANMAR (6.0% share, $2.0M). These five markets account for 58.0% of total export value.

Q: What is the HS code for imipenem exports from India?

The primary HS code for imipenem exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of imipenem exports from India?

The average unit price for imipenem exports from India is $4.71 USD per unit, with prices ranging from $0.08 to $119.08 depending on formulation, packaging, and order volume. The total market is valued at $33.3M across 803 shipments.

Q: Which ports handle imipenem exports from India?

The primary ports for imipenem exports from India are DELHI AIR CARGO ACC (INDEL4) (14.2% of shipments), DELHI AIR (10.3% of shipments), SAHAR AIR (9.5% of shipments), SAHAR AIR CARGO ACC (INBOM4) (7.1% of shipments), NHAVA SHEVA SEA (INNSA1) (4.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of imipenem?

India is one of the world's leading exporters of imipenem due to its large base of 140 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports imipenem to 94 countries, demonstrating 48% global market coverage.

Q: What certifications do Indian imipenem exporters need?

Indian imipenem exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import imipenem from India?

There are 302 registered buyers importing imipenem from India, spread across 94 countries. The repeat buyer rate is 45.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top imipenem supplier from India?

VENUS REMEDIES LIMITED is the leading imipenem exporter from India with a market share of 40.6% and total export value of $13.5M across 194 shipments. The top 5 suppliers together control 79.7% of total export value.

Suresh Sormare

Imipenem

India Pharmaceutical Trade Intelligence

$33.3M140 Suppliers94 CountriesHS 30049099

ExportsIndia → MEXICO27.2%India → BELGIUM10.0%

ImportsUNITED KINGDOM → India$131.3K UNITED STATES → India$111.3K

#1 Supplier: VENUS REMEDIES

Imipenem Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Imipenem to the World

Between 2022 and 2026, India exported $33.3M worth of imipenem across 803 verified shipments to 94 countries — covering 48% of world markets in the Advanced Antibiotics segment. The largest destination is MEXICO (27.2%). VENUS REMEDIES LIMITED leads with a 40.6% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Imipenem export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Imipenem export data snapshot — $33.3M · 140 exporters · 94 countriesTransData Nexus · Indian Customs Data

Top Imipenem Exporters from India

140 active exporters · Ranked by export value

View all 140 →

Top Imipenem Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	VENUS REMEDIES LIMITED	$13.5M	194	27	40.6%
2	SUN PHARMACEUTICAL INDUSTRIES LIMITED

Top Countries Importing Imipenem from India

94 destination markets · Ranked by import value

All 94 countries →

Top Countries Importing Imipenem from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	MEXICO	$9.1M	27.2%
2	BELGIUM	$3.3M	10.0%
3	SRI LANKA	$2.5M	7.4%
4	MOROCCO	$2.5M	7.4%
5	MYANMAR	$2.0M	6.0%
6	CHILE	$1.5M	4.4%
7	ECUADOR	$1.4M	4.2%
8	SAUDI ARABIA	$1.4M	4.0%
9	VIETNAM	$902.2K	2.7%
10	PERU	$871.6K	2.6%

MEXICO is India's largest imipenem export destination, absorbing 27.2% of total exports worth $9.1M. The top 5 importing countries — MEXICO, BELGIUM, SRI LANKA, MOROCCO, MYANMAR — together account for 58.0% of India's total imipenem export value. The remaining 89 destination countries collectively receive the other 42.0%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Imipenem to India?

2 origin countries · Total import value: $242.6K

India imports imipenem from 2 countries with a combined import value of $242.6K. The largest supplier is UNITED KINGDOM ($131.3K, 1 shipments), followed by UNITED STATES. All values are from Indian Customs (DGFT) import records.

Countries Supplying Imipenem to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED KINGDOM	$131.3K	1	54.1%
2	UNITED STATES	$111.3K	2	45.9%

UNITED KINGDOM is the largest supplier of imipenem to India, accounting for 54.1% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Imipenem

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, imipenem is marketed in combination with cilastatin and relebactam under the brand name Recarbrio, approved by the FDA for treating hospital-acquired pneumonia and other serious infections. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for imipenem-cilastatin combinations, indicating a competitive generic market. As of January 2026, there are no specific FDA import alerts targeting imipenem products from India. However, general import alerts, such as Import Alert 55-05 issued in November 2025, address concerns over microbiological contamination in drug products, underscoring the importance of stringent quality control measures for Indian exporters.

2EU & UK Regulatory Framework

In the European Union, imipenem, in combination with cilastatin and relebactam, is authorized under the brand name Recarbrio. The European Medicines Agency (EMA) granted marketing authorization for Recarbrio on April 23, 2020, for treating infections caused by aerobic Gram-negative organisms in adults with limited treatment options. (ema.europa.eu) The UK's Medicines and Healthcare products Regulatory Agency (MHRA) aligns with EMA standards, requiring compliance with Good Manufacturing Practice (GMP) guidelines for marketing authorization.

3WHO Essential Medicines & Global Standards

Imipenem is included in the World Health Organization's (WHO) Model List of Essential Medicines, highlighting its critical role in healthcare. The drug is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and efficacy across different regions.

4India Regulatory Classification

In India, imipenem is classified under Schedule H of the Drugs and Cosmetics Act, indicating it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates its pricing to ensure affordability. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC), ensuring compliance with international standards and regulations.

5Patent & Exclusivity Status

The primary patents for imipenem have expired, leading to a competitive generic market with multiple manufacturers producing the drug. This has resulted in increased availability and affordability of imipenem globally.

6Recent Industry Developments

In November 2025, the FDA issued Import Alert 55-05, focusing on the detention without physical examination of drug products due to potential microbiological contamination. This underscores the necessity for Indian exporters to maintain rigorous quality control measures to ensure compliance with international standards.

In January 2026, the EMA updated its guidelines on the use of carbapenem antibiotics, including imipenem, emphasizing the need for prudent use to combat antimicrobial resistance. This development may influence prescribing patterns and demand for imipenem in European markets.

These developments highlight the dynamic regulatory environment surrounding imipenem and the importance of continuous monitoring to ensure compliance and market competitiveness.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Imipenem

Retail & reference prices across 9 markets vs. India FOB export price of $4.71/unit

Global Price Benchmark for Imipenem across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$45	USD	According to the FDA's Orange Book, Imipenem is approved for intravenous use, with pricing subject to market dynamics and insurance coverage.
United Kingdom	$40	GBP	The NHS Drug Tariff lists Imipenem for hospital use, with prices negotiated through NHS procurement channels.
Germany	$38	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates Imipenem, with pricing influenced by statutory health insurance agreements.
Australia

Supply Chain Risk Assessment — Imipenem

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry heavily relies on China for Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs), with imports accounting for over 70% of bulk drug requirements. This dependency poses significant risks, as evidenced by supply chain disruptions in recent years. For instance, in July 2018, environmental regulations led to the shutdown of several Chinese chemical plants, causing a surge in raw material prices and supply shortages for Indian manufacturers.

To mitigate such vulnerabilities, the Indian government launched the Production Linked Incentive (PLI) Scheme for Bulk Drugs in July 2020, aiming to boost domestic manufacturing of critical KSMs, DIs, and APIs. By September 2025, the scheme had facilitated the creation of production capacities for 26 KSMs/APIs, resulting in cumulative sales of ₹2,315 crore and avoiding imports worth ₹1,807 crore.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of Imipenem from India account for 79.7% of the total export value, with VENUS REMEDIES LIMITED alone contributing 40.6%. This high supplier concentration exposes the supply chain to significant risks, as disruptions affecting these key players could severely impact global availability.

The PLI Scheme for Pharmaceuticals, initiated in March 2021, aims to diversify and strengthen the supplier base by incentivizing domestic production of high-value pharmaceutical products. As of September 2025, the scheme had attracted a committed investment of ₹17,275 crore, surpassing the initial target, and had already achieved an actual investment of ₹40,890 crore.

Access Complete Imipenem Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 803 transactions across 94 markets.

Request Demo View Pricing

Frequently Asked Questions — Imipenem Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top imipenem exporters from India?

The leading imipenem exporters from India are VENUS REMEDIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, SWISS PARENTERALS LIMITED, and 11 others. VENUS REMEDIES LIMITED leads with 40.6% market share ($13.5M). The top 5 suppliers together control 79.7% of total export value.

What is the total export value of imipenem from India?

The total export value of imipenem from India is $33.3M, recorded across 803 shipments from 140 active exporters to 94 countries. The average shipment value is $41.5K.

Which countries import imipenem from India?

India exports imipenem to 94 countries. The top importing countries are MEXICO (27.2%), BELGIUM (10.0%), SRI LANKA (7.4%), MOROCCO (7.4%), MYANMAR (6.0%), which together account for 58.0% of total export value.

What is the HS code for imipenem exports from India?

The primary HS code for imipenem exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Imipenem

Imipenem

Top Imipenem Exporters from India

Top Countries Importing Imipenem from India

Who Supplies Imipenem to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Regulatory Landscape — Imipenem

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Imipenem

Supply Chain Risk Assessment — Imipenem

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Imipenem Trade Intelligence

Frequently Asked Questions — Imipenem Exports from India

Who are the top imipenem exporters from India?

What is the total export value of imipenem from India?

Which countries import imipenem from India?

What is the HS code for imipenem exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of imipenem exports from India?

Which ports handle imipenem exports from India?

Why is India a leading exporter of imipenem?

What certifications do Indian imipenem exporters need?

How many buyers import imipenem from India?

What is the market share of the top imipenem exporter from India?

Analysis Methodology